User login
Article Type
Changed
Tue, 05/03/2022 - 15:22
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
Click Here to Read the Supplement.
Topics include:
- Medications for Type 2 Diabetes Mellitus: A Work in Progress
- Role of Injectable Medications in Type 2 Diabetes Treatment
- Basal Insulins
- Glucagon-Like Peptide-1 Receptor Agonists
- Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist
Issue
The Journal of Family Practice - 66(10)
Topics
Sections
Click Here to Read the Supplement.
Topics include:
- Medications for Type 2 Diabetes Mellitus: A Work in Progress
- Role of Injectable Medications in Type 2 Diabetes Treatment
- Basal Insulins
- Glucagon-Like Peptide-1 Receptor Agonists
- Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist
Click Here to Read the Supplement.
Topics include:
- Medications for Type 2 Diabetes Mellitus: A Work in Progress
- Role of Injectable Medications in Type 2 Diabetes Treatment
- Basal Insulins
- Glucagon-Like Peptide-1 Receptor Agonists
- Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist
Issue
The Journal of Family Practice - 66(10)
Issue
The Journal of Family Practice - 66(10)
Topics
Article Type
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
Display Headline
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica